JPRN-UMIN000023806招募中2 期
Immunotherapy with fusions of glioma cells, glioma initiating cells, and dendritic cells for patients with malignant glioma - Dendritic cell-based immunotherapy for patients with malignant glioma
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)A patient who has an allergy to biological medicines. 2)A patient who has a past or current history of autoimmune disease. 3)A patient who has positive of HBs antigen, HIV antibody, HCV antibody, or HTLV antibody. 4)A patient who has sever immune deficiency. 5)A patient who is administrated steroids for a long period, and is difficult to stop it. 6)A patient who has sever infectious disease. 7)A patient who has sever lung disease (Class 3 or more in the Hugh-Jones classification). 8)A patient who has sever heart disease (Class 3 or more in the NYHA). 9)A patient who has uncontrollable diabetes. 10)A pregnant or lactating patient. 11)A patient who is involved in other clinical trials.
研究者
相似试验
招募中
2 期
Glioma-immunotherapy with fusions of dendritic and glioma cells.Malignant gliomaJPRN-jRCTc030190122Akasaki Yasuharu50
进行中（未招募）
不适用
Imune therapy of High Grade Glioma with dendritic cell vaccination. A phase II study.High grade gliomaEUCTR2007-003513-14-SEDepartment of Neurology, Karolinska University Hospital
已完成
1 期
Cellular Immunotherapy Study for Brain CancerGliomasAnaplastic AstrocytomaAnaplastic OligodendrogliomaAnaplastic Mixed GliomaMalignant MeningiomaGlioblastoma MultiformeNCT01144247Jonsson Comprehensive Cancer Center10
终止
1 期
Immunogene-modified T (IgT) Cells Against Glioblastoma MultiformeNCT03170141Shenzhen Geno-Immune Medical Institute30
已完成
2 期
Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or OligodendrogliomaBrain and Central Nervous System TumorsNCT00004024Barbara Ann Karmanos Cancer Institute60